Squarepoint
RLAY icon

Squarepoint’s Relay Therapeutics RLAY Stock Holding History

Squarepoint’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Sell
93,179
-87,119
-48% -$1.26M ﹤0.01% 2457
2026
Q1 		$1.79M Buy
180,298
+86,088
+91% +$770K ﹤0.01% 2257
2025
Q4 		$797K Buy
+94,210
New +$672K ﹤0.01% 2808
2025
Q3 		– Sell
-87,551
Closed -$303K – 4894
2025
Q2 		$303K Sell
87,551
-27,068
-24% -$80.5K ﹤0.01% 3680
2025
Q1 		$300K Sell
114,619
-47,969
-30% -$188K ﹤0.01% 3732
2024
Q4 		$670K Buy
162,588
+137,020
+536% +$746K ﹤0.01% 3461
2024
Q3 		$181K Sell
25,568
-119,418
-82% -$892K ﹤0.01% 3721
2024
Q2 		$945K Buy
+144,986
New +$991K ﹤0.01% 2595
2023
Q4 		– Sell
-121,544
Closed -$1.02M – 4416
2023
Q3 		$1.02M Buy
121,544
+91,215
+301% +$981K ﹤0.01% 2301
2023
Q2 		$381K Buy
+30,329
New +$377K ﹤0.01% 2812
2023
Q1 		– Sell
-13,904
Closed -$208K – 3721
2022
Q4 		$208K Sell
13,904
-25,258
-64% -$483K ﹤0.01% 2767
2022
Q3 		$876K Buy
39,162
+3,731
+11% +$81.9K ﹤0.01% 1855
2022
Q2 		$593K Buy
35,431
+14,505
+69% +$311K ﹤0.01% 1912
2022
Q1 		$626K Buy
+20,926
New +$508K ﹤0.01% 1878
2020
Q4 		– Sell
-6,212
Closed -$265K – 3209
2020
Q3 		$265K Buy
+6,212
New +$237K ﹤0.01% 1898

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Squarepoint's RLAY Position: Q2 2026 in Review

Squarepoint reduced its Relay Therapeutics (RLAY) stake by 48% in Q2 2026, selling an estimated $1.26M and leaving 93,179 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #2457.

Squarepoint first reported a position in RLAY in Q3 2020 and has held it in 15 quarters since. The position peaked at $1.79M in Q1 2026. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Squarepoint held 93,179 shares of Relay Therapeutics worth $1.74M as of Q2 2026.
  • Squarepoint sold 87,119 Relay Therapeutics shares in Q2 2026, an estimated $1.26M.
  • Relay Therapeutics made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2457 holding.
  • Squarepoint first reported a position in Relay Therapeutics in Q3 2020 and has held it in 15 quarters since.
  • Squarepoint's Relay Therapeutics position peaked at $1.79M in Q1 2026.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.